261 related articles for article (PubMed ID: 30998907)
1. Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model.
Precazzini F; Pancher M; Gatto P; Tushe A; Adami V; Anelli V; Mione MC
Dev Biol; 2020 Jan; 457(2):215-225. PubMed ID: 30998907
[TBL] [Abstract][Full Text] [Related]
2. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.
Santoriello C; Gennaro E; Anelli V; Distel M; Kelly A; Köster RW; Hurlstone A; Mione M
PLoS One; 2010 Dec; 5(12):e15170. PubMed ID: 21170325
[TBL] [Abstract][Full Text] [Related]
3. Reprofiling using a zebrafish melanoma model reveals drugs cooperating with targeted therapeutics.
Fernandez Del Ama L; Jones M; Walker P; Chapman A; Braun JA; Mohr J; Hurlstone AF
Oncotarget; 2016 Jun; 7(26):40348-40361. PubMed ID: 27248171
[TBL] [Abstract][Full Text] [Related]
4. A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.
Stueven NA; Schlaeger NM; Monte AP; Hwang SL; Huang CC
Toxicol Appl Pharmacol; 2017 Dec; 337():30-38. PubMed ID: 29042215
[TBL] [Abstract][Full Text] [Related]
5. BEL β-Trefoil Reduces the Migration Ability of RUNX2 Expressing Melanoma Cells in Xenotransplanted Zebrafish.
Valenti MT; Marchetto G; Perduca M; Tiso N; Mottes M; Dalle Carbonare L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168858
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the Antitumor Activity of Clotrimazole on A375 Human Melanoma Cells.
Adinolfi B; Carpi S; Romanini A; Da Pozzo E; Castagna M; Costa B; Martini C; Olesen SP; Schmitt N; Breschi MC; Nieri P; Fogli S
Anticancer Res; 2015 Jul; 35(7):3781-6. PubMed ID: 26124322
[TBL] [Abstract][Full Text] [Related]
7. Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo.
Taylor SA; Marrinan CH; Liu G; Nale L; Bishop WR; Kirschmeier P; Liu M; Long BJ
Gynecol Oncol; 2008 Apr; 109(1):97-106. PubMed ID: 18237771
[TBL] [Abstract][Full Text] [Related]
8. Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma.
Mahgoub T; Eustace AJ; Collins DM; Walsh N; O'Donovan N; Crown J
Int J Oncol; 2015 Sep; 47(3):900-8. PubMed ID: 26201960
[TBL] [Abstract][Full Text] [Related]
9. Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells.
Raineri A; Prodomini S; Fasoli S; Gotte G; Menegazzi M
Biochem Pharmacol; 2019 Sep; 167():173-181. PubMed ID: 31185226
[TBL] [Abstract][Full Text] [Related]
10. Identification of a small molecule that downregulates MITF expression and mediates antimelanoma activity in vitro.
Cheng C; Yang HW; Shang JF; Li WW; Sun QZ; Chen X; Cao ZX; Yao SH; Yang SY
Melanoma Res; 2016 Apr; 26(2):117-24. PubMed ID: 26684062
[TBL] [Abstract][Full Text] [Related]
11. Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPARγ.
Zhang W; Shao W; Dong Z; Zhang S; Liu C; Chen S
Cell Death Dis; 2019 May; 10(6):404. PubMed ID: 31138783
[TBL] [Abstract][Full Text] [Related]
12. Characterization of two novel small molecules targeting melanocyte development in zebrafish embryogenesis.
Chen L; Ren X; Liang F; Li S; Zhong H; Lin S
Pigment Cell Melanoma Res; 2012 Jul; 25(4):446-53. PubMed ID: 22574862
[TBL] [Abstract][Full Text] [Related]
13. Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells.
Margue C; Philippidou D; Kozar I; Cesi G; Felten P; Kulms D; Letellier E; Haan C; Kreis S
J Exp Clin Cancer Res; 2019 Feb; 38(1):56. PubMed ID: 30728057
[TBL] [Abstract][Full Text] [Related]
14. Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes.
Kenyon A; Gavriouchkina D; Zorman J; Chong-Morrison V; Napolitani G; Cerundolo V; Sauka-Spengler T
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666124
[TBL] [Abstract][Full Text] [Related]
15. Indicaxanthin from Opuntia Ficus Indica (L. Mill) impairs melanoma cell proliferation, invasiveness, and tumor progression.
Allegra M; De Cicco P; Ercolano G; Attanzio A; Busà R; Cirino G; Tesoriere L; Livrea MA; Ianaro A
Phytomedicine; 2018 Nov; 50():19-24. PubMed ID: 30466978
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal Zn
Du W; Gu M; Hu M; Pinchi P; Chen W; Ryan M; Nold T; Bannaga A; Xu H
Cell Rep; 2021 Oct; 37(3):109848. PubMed ID: 34686351
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma.
Petrachi T; Romagnani A; Albini A; Longo C; Argenziano G; Grisendi G; Dominici M; Ciarrocchi A; Dallaglio K
Oncotarget; 2017 Jan; 8(4):6914-6928. PubMed ID: 28036292
[TBL] [Abstract][Full Text] [Related]
18. Application of the Transcriptional Disease Signature (TDSs) to Screen Melanoma-Effective Compounds in a Small Fish Model.
Lu Y; Boswell W; Boswell M; Klotz B; Kneitz S; Regneri J; Savage M; Mendoza C; Postlethwait J; Warren WC; Schartl M; Walter RB
Sci Rep; 2019 Jan; 9(1):530. PubMed ID: 30679619
[TBL] [Abstract][Full Text] [Related]
19. Anthelmintic activity of cytochrome P450 inhibitors miconazole and clotrimazole: in-vitro effect on the liver fluke Opisthorchis felineus.
Mordvinov VA; Shilov AG; Pakharukova MY
Int J Antimicrob Agents; 2017 Jul; 50(1):97-100. PubMed ID: 28527633
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
Gowda R; Sharma A; Robertson GP
Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
